What question did this study set out to answer?

To evaluate the impact of adding radiotherapy to first-line chemotherapy on survival in patients with locally advanced pancreatic cancer.

April 3, 2026Cancer Reports0 citationsOpen Access

View Full Paper

Effect of First‐Line Chemotherapy Alone Versus First‐Line Chemotherapy Plus Radiotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer in the IMRT Era: A Retrospective Cohort Study

ZLZihao LiuShandong First Medical University YTYi TianHuazhong Agricultural University JMJi MaShandong Provincial QianFoShan Hospital

Key Points

To evaluate the impact of adding radiotherapy to first-line chemotherapy on survival in patients with locally advanced pancreatic cancer.
Conducted a retrospective cohort study
Compared outcomes of first-line chemotherapy alone versus chemotherapy plus IMRT
Analyzed disease control rate, progression-free survival, and overall survival using statistical tests
Combination therapy improved disease control rate (DCR) significantly (p = 0.038)
No significant difference in progression-free survival (PFS) between groups (p = 0.465)
Overall survival (OS) also showed no significant difference (p = 0.156)

Abstract

The combination of first-line chemotherapy and IMRT improves the DCR rate (p = 0.038) and was well tolerated. However, first-line chemotherapy plus IMRT had no significant difference in PFS (p = 0.465) and OS (p = 0.156) compared with chemotherapy alone.

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper

Effect of First‐Line Chemotherapy Alone Versus First‐Line Chemotherapy Plus Radiotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer in the IMRT Era: A Retrospective Cohort Study

Key Points

Abstract

Cite This Study